Europlasma Financial Statements From 2010 to 2024
| ALEUP Stock | EUR 0.03 0 5.54% |
Check Europlasma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Europlasma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Europlasma financial statements analysis is a perfect complement when working with Europlasma Valuation or Volatility modules.
Europlasma |
Europlasma SA Company Current Valuation Analysis
Europlasma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Europlasma Current Valuation | 6.76 M |
Most of Europlasma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Europlasma SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Europlasma SA has a Current Valuation of 6.76 M. This is 99.91% lower than that of the Commercial Services & Supplies sector and 99.93% lower than that of the Industrials industry. The current valuation for all France stocks is 99.96% higher than that of the company.
Europlasma SA Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Europlasma's current stock value. Our valuation model uses many indicators to compare Europlasma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Europlasma competition to find correlations between indicators driving Europlasma's intrinsic value. More Info.Europlasma SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Europlasma's earnings, one of the primary drivers of an investment's value.About Europlasma Financial Statements
Europlasma shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Europlasma investors may analyze each financial statement separately, they are all interrelated. The changes in Europlasma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Europlasma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Europlasma S.A., together with its subsidiaries, engages in plasma solutions, renewable energies, and asbestos waste treatment activities in France. Europlasma S.A. was founded in 1992 and is based in Pessac, France. EUROPLASMA operates under Waste Management classification in France and is traded on Paris Stock Exchange. It employs 116 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Europlasma Stock Analysis
When running Europlasma's price analysis, check to measure Europlasma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Europlasma is operating at the current time. Most of Europlasma's value examination focuses on studying past and present price action to predict the probability of Europlasma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Europlasma's price. Additionally, you may evaluate how the addition of Europlasma to your portfolios can decrease your overall portfolio volatility.